BioSpace News Archive

Business

Applied DNA Schedules Fiscal 2022 Second Quarter Financial Results Conference Call and Webcast for Thursday, May 12, 2022

Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in cell-free, enzymatic DNA production, today announced that it will report fiscal 2022 second quarter financial results after market close on Thursday, May 12, 2022.

May 9, 2022
·
2 min read
Business

BIOQUAL, Inc. CFO Announces Retirement and Appointment to BIOQUAL Board

BIOQUAL, Inc., announced that Dave Newcomer will retire from his role as Chief Financial Officer effective June 3, 2022.

May 9, 2022
·
2 min read
Business

Hitachi High-Tech and Invivoscribe partner to advance molecular diagnostics and precision medicine

Hitachi High-Tech Corporation (“Hitachi High-Tech”) has entered into a strategic partnership (the Partnership) with Invivoscribe, Inc. (“Invivoscribe”), a global provider of blood cancer testing kits and services, by undertaking a minority investment-based, third-party allotment of shares.

May 9, 2022
·
4 min read
Drug Development

Arcellx Announces Publication in Blood Advances of Clinical Results from the Dose Escalation Cohorts of its CART-ddBCMA Phase 1 Study in Patients with Relapsed or Refractory Multiple Myeloma

Arcellx, Inc. (NASDAQ: ACLX), today announced the publication of clinical data from its dose escalation cohorts in its ongoing Phase 1 study of CART-ddBCMA for the treatment of patients with relapsed or refractory multiple myeloma (r/r MM).

May 9, 2022
·
5 min read
Business

Krystal Biotech Announces First Quarter 2022 Financial Results and Reports Updates on Operational Progress

Krystal Biotech, Inc., (the “Company”) (NASDAQ: KRYS), the leader in redosable gene therapy, today reported financial results and key operational progress updates for the first quarter ending March 31, 2022.

May 9, 2022
·
7 min read
Business

Akebia Therapeutics Reports First Quarter 2022 Financial Results and Business Update

Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced financial results for the first quarter ended March 31, 2022 and provided business updates.

May 9, 2022
·
14 min read
Business

Nuvation Bio Reports First Quarter 2022 Financial Results and Provides Business Update

Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today reported its financial results for the first quarter ended March 31, 2022, and provided a business update.

May 9, 2022
·
9 min read
Business

Cellarity Appoints Dr. Sandra Horning to Board of Directors

Cellarity announced today the appointment of Sandra Horning, M.D., to the Company’s Board of Directors.

May 9, 2022
·
4 min read
Genetown

Finch Therapeutics to Host Corporate Update Conference Call and Webcast on May 16, 2022

Finch Therapeutics Group, Inc. today announced it will host a conference call and live webcast on Monday, May 16, 2022 at 8:00am ET to discuss updates to its development programs and other business highlights.

May 9, 2022
·
1 min read
Business

Catalyst Biosciences Reports First Quarter 2022 Operating & Financial Results

Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced its operating and financial results for the first quarter ended March 31, 2022.

May 9, 2022
·
6 min read